A new clinical trial suggests that regular exercise could be just as effective as certain medications in preventing colon cancer from coming back after treatment. It’s a big deal because it highlights how lifestyle changes might pack a serious punch in cancer recovery—no prescription required.

Scientists have developed a simple blood test that can give breast cancer patients an early heads-up if their prescribed drugs are starting to lose effectiveness. Instead of waiting for scans or symptoms to show treatment failure, this test detects tiny cancer DNA fragments in the blood, allowing doctors to switch therapies faster—potentially improving outcomes.

When hit with a cancer diagnosis, patients naturally scramble for ways to improve their chances. Surprisingly, doctors are pointing to simple, foundational habits—like better sleep, nutrition, and stress management—as potential game-changers. New data suggests these basics might boost survival odds or treatment response, a reminder that cutting-edge medicine isn’t the only tool in the fight.

BioNTech, the German biotech firm famous for its COVID-19 vaccine, just struck a massive deal with pharmaceutical giant Bristol Myers Squibb to co-develop a promising cancer drug called BNT327. The agreement could net BioNTech over $11 billion if the drug succeeds—a huge bet on the next frontier of cancer treatment.

The UK's National Health Service (NHS) is making a big move in cancer detection by introducing liquid biopsies—simple blood tests—as part of routine lung cancer screening. This cutting-edge approach could spot tumors earlier and with less hassle than traditional methods like tissue biopsies or scans.

A groundbreaking study reveals that increasing physical activity can significantly boost survival rates for colon cancer patients. Researchers found that those who ramped up their exercise levels slashed their risk of dying by a staggering one-third. This isn’t just about general health—it’s a direct lifeline for cancer survivors.

Scientists have found that simple blood tests, called "liquid biopsies," can help doctors better manage treatment for advanced breast cancer patients. These tests detect changes in the tumor early, allowing doctors to switch medications before the cancer progresses—keeping the disease in check for over a year in some cases.

Novartis’s prostate cancer drug Pluvicto just cleared a big hurdle—it showed promising results in a trial for patients with advanced, hormone-sensitive prostate cancer that has spread. The treatment targets a specific protein (PSMA) found in these tumors, offering hope for a group that often faces limited options.

A groundbreaking new approach to treating cancer has shown remarkable results in a major international trial. The study found that giving patients immunotherapy before surgery—rather than after—could potentially double their survival time, offering hope for longer, healthier lives.